GILEAD SCIENCES INC (GILD) - Price, trends, fundamentals and chart - Passport to Wall Street

GILEAD SCIENCES INC (NASDAQ: GILD)

Overview

current price

$65.27

$65.27

change

-1.81 | -2.70%

-1.81 | -2.70%

Yesterday's Close

67.08

open

67.47

volume

13.95 M

30d. avg volume.

6.85 M

1 day

65.09 - 67.90

52 weeks

65.90 - 87.87

p/e

14.91

beta

0.1883

market cap

83.65 B

dividend yield

4.59%

Industry

-

News and Commentary

Market Update: Dow Closes Above 38,000 First Time, S&P 500 Sets New All-Time High Stocks rose to record levels on Monday as investors continued to build on Wall Street's recent momentum. The Dow Jones Industrial Average climbed nearly 140 points to close above...

AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains AbbVie Inc (ABBV ...

Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions Gilead Sciences Inc (GILD

Pfizer Decides To Raise COVID-19 Treatment Pill Price, Defends Itself Amid Criticism for Cost Increa... Pfizer Inc (PFE

$1 Billion Deal For Moderna To Expand Product Pipeline In China The defensive stocks sector has been underperforming most - if not all - of the remaining cyclical sectors in the U.S. economy. These preferences come from underlying dynamics in...

October 28 Market Summary Global investors on Friday digested new data, policy statements, and earnings reports. In Europe, the MOEX Russia Index edged up 0.14%, the British FTSE dipped 0.37%, the German...

FDA Clears Gilead’s Remdesivir for the Treatment of Children The U.S. Food and Drug Administration (FDA) announced earlier this week that it was approving Gilead Sciences'

FDA Withdraws Authorization for Regeneron and Eli Lilly Antibody Treatments For Use The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for monoclonal antibody treatments manufactured by Regeneron

Pfizer Submits EUA Application to FDA for COVID Treatment Pill Pfizer (PFE

October 29 Market Update Global investors on Friday digested new data, policy statements, and earnings reports. In Europe, the British FTSE edged down 0.16%, the German DAX edged down 0.05%, the French C...

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more